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ABSTRACT
PHENYLEPHRINE VERSUS EPHEDRINE: SAFEST VASOPRESSOR FOR THE
NEONATE DURING CAESAREAN SECTION
by James Stacey Hale Jr.
December 2015
One of the most common side effects of spinal anesthesia is the development of
hypotension. Data collected has determined that 80% of parturients that undergo spinal
anesthesia for this mode of delivery experience hypotension (Chestnut et al., 2014).
Hypotension, if sustained and severe, can lead to fetal hypoxia, neonatal depression or
injury, and decreased uteroplacental perfusion. Hypotension can also cause severe health
issues for the parturient including apnea, altered level of consciousness, cardiac arrest,
and pulmonary aspiration. This systematic review of the literature was conducted to
determine whether the administration of phenylephrine or ephedrine was safer for the
neonate to administer to a hypotensive parturient during cesarean delivery while
undergoing a spinal anesthetic. Inclusion criteria included parturients that were classified
as an American Society of Anesthesiologists physical status score of II that experienced
hypotension after undergoing spinal anesthesia for elective cesarean section. Exclusion
criteria included any parturient classified as an ASA physical status score > 2, any
cesarean section classified as emergent, or those parturients that received an epidural as
the method of anesthesia for elective cesarean section. A systematic review of the
literature was performed and the results of randomized control trials and other studies
were analyzed that measured neonatal outcomes following the administration of
ephedrine and phenylephrine to the hypotensive parturient. The results of these studies
ii

were disseminated and the conclusions reached were implemented into a white paper
change proposal.
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CHAPTER I
INTRODUCTION
Statement of the Problem
The most commonly performed major surgical procedure in the United States
today is cesarean delivery, accounting for more than 1 million procedures each year and
approximately 30% of all births (Chestnut et al., 2014). Cesarean delivery is most
commonly defined as the birth of an infant through incisions made by the surgeon in the
abdomen and uterus. The most common indications for a cesarean delivery in parturients
include malpresentation, shoulder dystocia, previous cesarean section, and nonreassuring
fetal status. Malpresentation is the presentation of any part of the fetus other than the
back of the head during parturition. Shoulder dystocia is a serious complication that
occurs during vaginal delivery. After the head is delivered, the baby seems to be pulled
back into the perineum due to anterior shoulder being trapped above the pubic symphysis.
This complication occurs in as many as 3% of vaginal deliveries (Chestnut et al., 2014).
Nonreassuring fetal status is a term used when test results suggest that the fetus’s health
status may be in jeopardy because the fetus is not getting enough oxygen. This
complication usually occurs during labor in the late stages of pregnancy. Complications
of cesarean delivery include uterine rupture, infection, hemorrhage, ureteral and bladder
injury, abdominal pain, thromboembolism, and death. Thromboembolism is the
obstruction of a blood vessel with thrombotic material carried by the blood from the site
of origin to plug another vessel. The clot may plug a vessel in the brain, the lungs, the
leg, the kidneys, or the gastrointestinal tract.
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The most commonly preferred method of anesthesia for elective cesarean section
is with a neuraxial technique, which is a spinal, epidural, or a combined spinal epidural
(Chestnut et al., 2014). Of these three techniques, spinal anesthesia is the most
commonly used technique. Spinal anesthesia is a reliable and simple method that allows
for correct needle placement by visual confirmation of the cerebrospinal fluid (Chestnut
et al., 2014). This technique is easier to perform than the epidural method of anesthesia.
Spinal anesthesia delivers a fast onset of dense neuroblockade that is normally more
profound than that which is provided by the epidural technique. This results in a
decreased rate of conversion to general anesthesia and the decreased need for
supplemental intravenous analgesics. The disadvantage to using the single shot spinal
anesthetic method is it has a fixed duration of action and the anesthesia provider does not
have the ability to redose without invasively performing the spinal technique again.
Additionally, when spinal anesthesia is used as the anesthetic method for cesarean
delivery it causes maternal hypotension at a rate of 80% (Chestnut et al., 2014).
One of the most common side effects of spinal anesthesia is the development of
hypotension. Hypotension is the medical definition for low blood pressure. Blood
pressure is the measure of the pressure in the arteries that is created by the contraction of
the heart. The physical process of pregnancy increases dependence on the sympathetic
nervous system for the maintenance of systemic vascular resistance and venous return.
This dependence coupled with the increased risk of aortocaval compression makes
parturients more prone to hemodynamic instability and hypotension from neuraxial
anesthesia (Chestnut et al., 2014). Hypotension, if sustained and severe, can lead to fetal
hypoxia, neonatal depression or injury, and decreased uteroplacental perfusion.
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Hypotension can also cause severe health issues for the parturient including apnea,
altered level of consciousness, cardiac arrest, and pulmonary aspiration. Many strategies
have been implemented to prevent the incidence of hypotension secondary to spinal
anesthesia for cesarean delivery. Some of these strategies are preoperative fluid
administration, lower local anesthetic doses, left uterine displacement, vasopressor
administration, and leg wrapping or elevation. Left uterine displacement is the act of
placing the patient in 15 degrees of left lateral tilt on the operating table. This prevention
method is important to minimize aortocaval compression. Aortocaval compression, or
supine hypotension syndrome, is caused by compression of the inferior vena cava and
aorta by the gravid uterus. This syndrome can comprise uteroplacental blood flow by
decreasing cardio output and venous return (Chestnut et al., 2014).
This capstone project will compare the effects of ephedrine versus phenylephrine
in mothers undergoing spinal anesthesia during a cesarean delivery. This project will
examine the effects it has on neonates by performing a systematic review of the literature
by comparing Apgar scores and fetal cord blood pH in cases where parturients received
ephedrine and cases where they received phenylephrine. Some deleterious effects can
result in the neonate if impaired fetal oxygenation or fetal acidosis occurs.
Deleterious effects in the neonate that can occur are impaired fetal oxygenation
with asphyxial distress, fetal acidosis, and decreased uteroplacental blood flow (Lee,
Ngan Kee, & Gin, 2002). Although patients undergoing a spinal anesthetic are usually
preloaded with intravenous fluids, a vasopressor is often required to treat hypotension
after the spinal anesthetic takes effect. Historically, the vasopressor of choice to treat
hypotension for obstetric anesthesia has been ephedrine. According to Lee et al. (2002),
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this was based on observations researchers had when administering ephedrine to sheep.
The study showed that ephedrine maintained and preserved uteroplacental blood flow
better than other vasopressors. It also was the most effective in increasing arterial
pressure. This effect is rationalized by the β-effect, which causes an increase in arterial
blood pressure by increasing cardiac output rather than simply vasoconstriction.
Phenylephrine, a pure α agonist, on the other hand, fell into disfavor as a vasopressor in
obstetric anesthesia because of the decreased uteroplacental blood flow (Lee et al., 2002).
However, controversy exists today because many trials have shown that phenylephrine is
just as effective as ephedrine and has shown to possibly be a safer alternative for the
neonate.
Clinical Question
In parturients being treated for hypotension during cesarean section, does
treatment with phenylephrine or ephedrine produce a higher Apgar score for the neonate
while maintaining a normal arterial blood pH?
Purpose of the Project
The purpose of this project was to search the literature to determine whether
ephedrine or phenylephrine is safer for the neonate when administered to a parturient
with hypotension during elective cesarean section. The outcomes that were measured for
this study were Apgar scores recorded at 1 and 5 minutes and umbilical artery pH. These
are standard assessments that are performed following the removal of the neonate during
cesarean section that determine the current health status of the neonate.
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CHAPTER II
METHODOLOGY
After obtaining approval from the institutional review board (IRB) at the
University of Southern Mississippi, a systematic search of literature on electronic
databases was performed. Databases that were used in this search were the Cochrane
Library, Google Scholar, PubMed, and MEDLINE. The search strategy that was
incorporated was the search for the following key words in the text: “hypotension”,
“cesarean delivery”, “phenylephrine”, “ephedrine”, “spinal anesthesia”, and “neonatal
outcomes after spinal induced hypotension.” The outcomes measured were Apgar scores
at 1 and 5 minutes and umbilical arterial and venous pH values. These outcomes were
measured after the parturient was administered phenylephrine, ephedrine, or both for the
treatment of hypotension secondary to spinal anesthesia for elective cesarean section. The
results of these studies were compiled and the conclusions reached were utilized in the
development of a white paper change proposal. This white paper change proposal was
distributed among local clinical sites to prevent the occurrence of fetal acidosis and
decreased Apgar scores following the administration of ephedrine and phenylephrine
during elective cesarean section.
Target Outcome
The goal of this capstone was to determine whether it is safer for the neonate to
administer ephedrine or phenylephrine to the hypotensive parturient during cesarean
delivery. The desired outcome was to improve patient safety by developing a practice
change policy based upon the findings of the systematic review of the literature. The
findings of this systematic review of the literature was implemented into a white paper
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change proposal and distributed to local clinical sites to increase knowledge on use of
these vasopressors, their effect on neonates and implications for decision-making and
clinical practice. This capstone project will hopefully contribute to decreasing the
occurrence of fetal acidosis and decreased Apgar scores following the administration of
ephedrine and phenylephrine during elective cesarean section.
Barriers
Several barriers were identified while performing this capstone project. There
were a limited amount of studies that measured the same neonatal outcomes when
comparing the administration of ephedrine versus phenylephrine to hypotensive
parturients following the administration of spinal anesthesia for cesarean delivery.
Additional barriers included finding studies that were completed within the last 10 years,
time constraints to complete the project, and studies that met the proper inclusion criteria.
Population
The population chosen for this capstone project was women over the age of 18
who were classified as an American Society of Anesthesiologists physical status score of
II that experienced hypotension after undergoing spinal anesthesia for elective cesarean
section. Anesthesia providers use the ASA scoring system to classify and define relative
risk prior to surgical anesthesia and conscious sedation. An ASA physical status score of
II is defined as a patient with mild systemic disease with no functional limitations
(Butterworth, Mackey, & Wasnick, 2013). Additionally, they had to be treated with
ephedrine, phenylephrine, or both. Exclusion criteria included any parturient classified as
an ASA physical status score > 2, any cesarean section classified as emergent, or those
parturients that received an epidural as the method of anesthesia for elective cesarean

7
section. An ASA physical status score of III is defined as patients with severe systemic
disease with some functional limitations (Butterworth et al., 2013). A total of nine studies
met this criteria and were included in this systematic review of the literature.
The Importance of Apgar Scores
The Apgar scoring system has been used to access the prognosis and overall
condition of the neonate since Virginia Apgar introduced it in 1952 (Casey, McIntire, &
Leveno, 2001). Dr. Apgar in her paper A Proposal for a New Method of Evaluation of
the Newborn Infant, described a simple and very reliable system for evaluating neonates
that revealed a way to detect physiological differences among neonates whose mothers
had been anesthetized for cesarean delivery by different techniques (Chestnut et al.,
2014). The evaluation method she proposed was based on a 10-point scale that observed
and measured five characteristics of newborns after delivery. This method measured the
neonate’s color, respiratory effort, muscle tone, heart rate, and reflex irritability (Casey et
al., 2001). Reflex irritability is the neonate’s response to a stimulus that is usually
created by oropharyngeal suctioning. The appropriate response is for the neonate to
actively cough or sneeze (Chestnut et al., 2014). After each of these easily identifiable
characteristics are assessed, they are then assigned a score on a scale from 0 to 2. The
scores are then added up to achieve a max score of 10 and that allows the providers an
easy way to evaluate the health status of the newborn. Overall, a score of 7 or higher
indicates that the neonate’s health condition is good to excellent. Apgar scores from 4 to
6 are considered fair for the neonate. The infant’s physical status is considered to be poor
with Apgar scores less than 4 (Chestnut et al., 2014). The Apgar score rapidly evaluates
the physical condition of neonates and is measured at 1 minute and 5 minutes after
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delivery. The 5-minute score has commonly been regarded as the best predictor of the
neonate’s survival in clinical practice (Casey et al., 2001).
The Apgar score has come under scrutiny as the standard scoring system for
newborns after delivery. Many clinicians and clinical investigators believe that the
measurement of pH in umbilical-artery blood is a more objective evaluation tool for
assessing neonates. Casey et al. (2001) conducted a retrospective cohort analysis to show
that the Apgar score is still as valuable an assessment tool as it was during the last 60
years. The study included 151,891 live-born singleton infants without malformations
who were delivered at 26 weeks of gestation or later. The sample was collected from an
inner-city public hospital from January 1988 to December 1998. The outcomes measured
were paired Apgar scores at 1 and 5 minutes and umbilical-artery blood pH out of
145,627 infants. The study analyzed which test best predicted newborn death during the
first 28 days after delivery. The results showed that the risk of neonatal death in term
neonates with five-minute Apgar scores of 0 to 3 was eight times the risk in term
neonates with umbilical- artery blood pH values of 7.0 or less (Casey et al., 2001). Thus
Casey, McIntire, and Leveno concluded that the five-minute Apgar score was a better
predictor of neonatal outcome than was the measurement of umbilical-artery blood pH.
The investigators determined that the Apgar scoring system is still a vital assessment tool
and accurate predictor of newborn survival (Casey et al., 2001).
The Importance of Umbilical-Artery Blood pH Measurements
The umbilical-artery blood pH measurement is a very important measurement and
reflects the neonate’s physical condition after delivery. According to Omo-Aghoja
(2014), the 26th Royal College of Obstetricians and Gynecologists study group on
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Intrapartum Fetal Surveillance recommended the measurement of umbilical blood pH and
base deficit as a tool to assess the neonate’s condition at birth. These measurements can
be and are largely considered a more objective indication of a newborn’s condition than
the Apgar score. Obtaining the blood sample and receiving the results however can be
delayed so an assessment of the neonate should immediately be done while awaiting
feedback from the umbilical blood gas (Omo-Aghoja, 2014). The American Congress of
Obstetricians and Gynecologists has recommended that cord blood pH measurements be
obtained in circumstances of low 5-minute Apgar score, abnormal fetal heart rate tracing,
severe growth restriction, cesarean delivery for fetal compromise, intrapartum fever,
multiple gestation, and maternal thyroid disease.
The major components of the umbilical cord blood that are analyzed are the pH,
PCO2, HCO3-, and PO2 (Chestnut et al., 2014). HCO3-, or Bicarbonate, is one of the
major buffers in the blood of the neonate (Omo-Aghoja, 2014). Another component of
the umbilical blood gas that is measured is the base excess or base deficit. The base
excess or deficit is basically a measure of the change in the buffering capacity of the
neonate’s umbilical cord blood. This value can be determined by the HCO3-, PCO2, and
pH. When the obstetrician obtains the umbilical cord sample, it is usually to obtain a
sample from both the umbilical vein and the umbilical artery. The umbilical vein
measurements reveal the quality of uteroplacental gas exchange and the condition of the
parturient (Chestnut et al., 2014). The umbilical artery measurements reflect the
condition of the neonate.
According to Omo-Aghoja (2014), small changes in pH can significantly affect
the function of various organ systems in the neonate including the cardiovascular system
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and the central nervous system. Fetal distress and a low Apgar score often accompany
this development. The common pH range for neonatal acidemia in most literature is from
7.00 to 7.2. However, there is a more significant correlation with adverse neonatal
outcomes when umbilical cord pH is less than 7.0 (Omo-Aghoja, 2014). According to
Omo-Aghoja, the fetal acid-base status correlates well with the Apgar scores of the
neonate. Exceptions can occur however in preterm infants, so clinician diligence and the
use of multiple assessment tools could be the most beneficial for the neonate.
Several factors can affect the umbilical arterial blood pH measurement. Neonates
that endure the stresses of labor tend to have lower pH measurements when compared to
neonates who were born via cesarean delivery without experiencing labor (Chestnut et
al., 2014). Neonates who are born to nulliparous women also have been documented to
have a lower pH than those who were born to parous women. Nulliparous women are
women that have not previously had a child. Parous women are those that have delivered
at least one child previously (Chestnut et al., 2014). Additionally, some studies have
yielded results that suggest that preterm infants have a higher incidence of acidemia when
compared to term infants. Preterm infants also routinely receive poor Apgar scores even
though their umbilical blood gas measurements are considered normal (Chestnut et al.,
2014). This is significant and provides another rationale for more than one method to be
used to assess the neonate after delivery.
Preventative Measures Currently Recommended to Prevent Hypotension
The most common preventive strategy used by anesthesia providers today is
intravenous fluid administration (Chestnut et al., 2014). The success of preventing
hypotension intraoperatively during cesarean section depends on the type of fluid
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administered whether it is a colloid or a crystalloid, the timing of the administration of
fluid, and the rate of fluid administration. A colloid is considered intravenous fluids
containing large molecules and proteins that tend to stay within the vascular space.
Examples of colloid solutions are Hetastarch, Albumin, and Dextran. Crystalloid
intravenous fluids are those that contain various concentrations of electrolytes and tend to
diffuse more readily out of the vascular space than colloid solutions. Common
crystalloid solutions are Lactated Ringers, Dextrose 5%, and Normal Saline. Some
studies conducted on this preventive therapy have determined crystalloids to be
minimally effective even administered at volumes of 2,000 milliliters to 3,000 milliliters.
A study conducted by Ueyama and others determined that after 30 minutes post
administration of a crystalloid solution that only 28% remained in the intravascular space.
In contrast, the administration of a colloid solution is a more promising alternative for
preventative therapy. The same study conducted by Ueyama on crystalloid
administration compared it to the administration of a colloid solution. The researchers
discovered that 30 minutes after the administration of a colloid that 100% of the solution
remained in the vascular space. However, the side effects to the administration of a
colloid solution to parturients make this an unpopular option to many anesthesia
providers. Some side effects of colloid administration that have been noted are allergic
reactions, pruritus, and coagulation abnormalities. The next step in treating hypotension
after intravenous fluid administration and the most successful option is the administration
of vasopressors.
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Use of Vasopressors
Vasopressors are drugs that are administered that cause the constriction of blood
vessels. This desired constriction of blood vessels results in an increase in blood
pressure. The main component common to all vasopressors is their ability to mimic some
of the sympathetic nervous system actions (Macarthur & Riley, 2007). The basic
components that differentiate the vasopressors are each drug’s ability to stimulate the
alpha or beta-receptor. Sympathomimetics all have the same basic structure, which
include the benzene ring based β-phenylenthylamine. According to Macarthur and Riley
(2007), the activity of the α and β-receptor is maximized if hydroxyl groups are attached
at the third and fourth carbons of the benzene ring. Compounds are considered synthetic
noncatecholamines if they do not have the hallmark hydroxyl groups on the third and
fourth carbons. The two most commonly used vasopressors in anesthesia practice are
ephedrine and phenylephrine and they are both included in the synthetic
noncatecholamine group.
Comparison of the Vasopressors Ephedrine and Phenylephrine
Ephedrine is a synthetic noncatecholamine sympathomimetic that stimulates both
alpha and beta-receptors directly and causes the release of endogenous catecholamines
indirectly that leads to several mechanisms of action (Nagelhout & Plaus, 2014). The
indirect effects of ephedrine are due to the stimulation of postganglionic sympathetic
nerve endings to release norepinephrine (Macarthur & Riley, 2007). Ephedrine produces
increases in blood pressure, heart rate, systemic vascular resistance, and cardiac output.
Ephedrine is not metabolized by monoamine oxidase enzyme deamination because it has
a α-methyl group. Additionally, catchol-O-methyltranserease enzymes do not metabolize
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it because it lacks the traditional hallmark hydroxyl groups. Consequently, its actions are
mainly terminated by reuptake in terminal nerve endings. Due to this, ephedrine is
primarily excreted relatively unchanged in urine (Macarthur & Riley, 2007). The dosage
of ephedrine ranges from 5 mg to 25 mg and has an immediate onset of action when
given via the intravenous route. The duration of action has been documented to last from
15 minutes up to 90 minutes usually based on the dosage given. The administration of
repeated 5 to 10 mg doses of Ephedrine can lead to tachyphylaxis, which results in a
significant decrease in the efficacy of the drug after subsequent dosing.
Phenylephrine is a direct acting pure alpha agonist that is commonly administered
to parturients that have episodes of hypotension during cesarean section. Phenylephrine
is considered a pure alpha agonist because it has strong alpha stimulating effects with
essentially no beta stimulation (Nagelhout & Plaus, 2014). Phenylephrine is metabolized
by rapid inactivation by monamine oxidase and catchol-O-methyltranserease. The dosage
of phenylephrine commonly administered intravenously is 50 to 200 micrograms and has
an immediate onset of action. According to Macarthur and Riley (2007), because of its
short duration of action, phenylephrine can also be administered by intravenous infusion
of 20 to 50 micrograms per minute. The duration of action of phenylephrine ranges from
5 to 20 minutes. Phenylephrine can cause a sharp rise in blood pressure due to the
significant increase in peripheral vasoconstriction by stimulating alpha-1 receptors. A
common side effect of phenylephrine is a reflex bradycardia that is produced after
baroreceptor stimulation due to the significant increase in peripheral resistance.
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What are Clinicians Using in Practice Now?
An electronic survey was conducted by Allen, Muir, George, and Habib that
included 292 members of the Society for Obstetric Anesthesia and Perinatology between
February and March 2007 to determine their preferences for preventing and treating
spinal-induced hypotension. Of the members using vasopressors for prophylaxis, 26%
used phenylephrine, 32% used ephedrine, and 33% based their choice on the parturient’s
heart rate. The group determined that for treatment, 23% used phenylephrine, 32% used
ephedrine, and 41% used either based on heart rate. The group concluded that significant
variations exist in the prevention and treatment of hypotension due to spinal anesthesia
but that ephedrine continues to be a more commonly used vasopressor than
phenylephrine.
Clinical Question
The incidence of hypotension is prevalent in parturients undergoing spinal
anesthesia for cesarean delivery. Cesarean deliveries account for 30% of all births in the
United States. The current anesthetic method of choice for cesarean delivery is spinal
anesthesia. Data collected determined that 80% of parturients that undergo spinal
anesthesia for this mode of delivery experience hypotension. A clinical question was
developed to determine whether the administration of phenylephrine or ephedrine was
safer for the neonate to administer to a hypotensive parturient during cesarean delivery
while undergoing a spinal anesthetic. In parturients being treated for hypotension during
cesarean section, does treatment with phenylephrine or ephedrine produce a higher Apgar
score for the neonate while maintaining a normal arterial blood pH?
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Research Strategies
To ascertain which vasopressor treatment modality for maternal hypotension is
more beneficial for the neonate during elective cesarean delivery, a systematic review of
the literature was conducted. A systematic review is a study that focuses on a research
question that attempts to identify and appraise research evidence relevant to that question.
Inclusion criteria included in this study were parturients that underwent spinal anesthesia
for elective cesarean section, were classified as ASA class II, and were treated with either
ephedrine or phenylephrine.
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CHAPTER III
SYSTEMATIC REVIEW OF LITERATURE
Traditionally, ephedrine has been the drug of choice in obstetrics to treat maternal
hypotension following neuraxial anesthesia. The rationale behind this line of thinking
from anesthesia providers was it was believed based on previous studies that ephedrine
maintains uterine blood flow better than phenylephrine. However, the most recent
studies indicated that phenylephrine has now been recommended as the first drug choice
following neuraxial anesthesia. The most commonly preferred method of anesthesia for
elective cesarean section is with a neuraxial technique, which is a spinal, epidural, or a
combined spinal epidural (Chestnut et al., 2014). Of these three techniques, spinal
anesthesia is the most commonly used technique. Spinal anesthesia delivers a fast onset
of dense neuroblockade that is normally more profound than that which is provided by
the epidural technique. Lee et al. (2002) performed a quantitative, systematic review of
randomized controlled trials of ephedrine versus phenylephrine for the management of
hypotension during cesarean delivery while under spinal anesthesia. The authors
performing the systematic review compared the efficacy and safety of ephedrine and
phenylephrine for the treatment and prevention of hypotension during cesarean delivery
while undergoing spinal anesthesia. In the study, seven randomized control trials were
eligible for use after the systematic search of electronic databases. The outcomes they
measured and assessed were maternal hypertension, hypotension, and bradycardia.
Neonatal Apgar scores and umbilical cord pH blood values were also studied. The
authors determined from the results that there was no difference between ephedrine and
phenylephrine in their efficacy for managing maternal hypotension (Lee et al., 2002).
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However, maternal bradycardia was more likely to occur with phenylephrine than with
ephedrine (relative risk of 4.79; 95% confidence interval, 1.47-15.60). Neonatal
umbilical arterial pH values were higher in women who were treated with phenylephrine
as compared to those treated with ephedrine. The authors determined from the results
that there was no difference between ephedrine and phenylephrine in the incidence of
Apgar scores less than 7 at 1 and 5 minutes and true fetal acidosis, which is umbilical
arterial pH value less than 7.2 (Lee et al., 2002). Lee et al. did not support the traditional
practice that ephedrine is the drug of choice for the management of maternal hypotension
during cesarean delivery while under spinal anesthesia.
Magalhaes, Goveia, de Araujo Ladeira, Nascimento, and Cavalcante Kluthcouski
(2009) conducted a randomized, double blind, prospective study with 60 women. The
women were separated randomly into two groups using sequential, sealed envelopes with
random numbers generated by a computer. The group studied the incidence of maternal
hypotension, maternal bradycardia, vomiting, Apgar scores at 1 and 5 minutes, and blood
gases of the neonatal umbilical cord blood. The 60 patients underwent spinal anesthesia
for cesarean section with bupivacaine and sufentanil and were divided into two groups to
receive prophylactic phenylephrine (Group P, n = 30, dose = 80 mcg) and ephedrine
(Group E, n = 30, dose = 10 mg). According to Nagelhout and Plaus (2014), bupivacaine
is traditionally the local anesthetic of choice when administering spinal anesthesia for
cesarean delivery. In the United States, it is administered via the intrathecal route, or
spinal route, and is formulated in a concentration of 0.75% in dextrose 8.25%. Sufentanil
is a narcotic that is commonly administered intrathecally in conjunction with bupivacaine
(Nagelhout & Plaus, 2014). The definition of hypotension the group used in their study
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was a blood pressure equal or lower than 80% of baseline values. Maternal hypotension
was treated with a bolus administration of the participant’s vasoconstrictor at 50% of the
initial dose. The results from the study determined that the mean dose of phenylephrine
used was 186.7 +/- 52.9 and the mean dose of ephedrine used was 14.8 +/- 3.8 mg
(Magalhaes et al., 2009). The incidence of hypotension was 70% in the ephedrine group
and 93% in the phenylephrine group. The group determined that the Apgar scores in the
first minute and the mean arterial pH of the neonatal umbilical cord blood were lower in
the Ephedrine group. The group determined that differences in the Apgar score in the
fifth minute were not evident. The authors concluded from the study that ephedrine was
more effective than phenylephrine in the prevention of hypotension (Magalhaes et al.,
2009). However, fetal repercussions were found to be less frequent with phenylephrine
and were transitory with the administration of ephedrine.
An updated meta-analysis on ephedrine versus phenylephrine for the management
of hypotension during cesarean section while undergoing spinal anesthesia was
conducted by Lin, Qui, Ding, Fu, and Li (2012). The aim of this study was to update a
systematic literature review that was previously conducted on the same topic in 2002.
The group used Medline, the Cochrane Library, and Embase Databases to search for the
criteria. The group examined a total of 15 trials and 742 parturients under elective
Cesarean Sections. They determined when patients received ephedrine and
phenylephrine for prevention of hypotension; results did not significantly differ in the
incidence of umbilical arterial pH values, hypotension, or venous pH values. The group
determined when ephedrine and phenylephrine were used to treat hypotension that the
results indicated both had similar incidence of perioperative hypotension but those
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patients receiving phenylephrine had neonates with higher venous pH values and
umbilical arterial pH values than those who had received ephedrine (Lin et al., 2012).
Thus, the group came to the conclusion that the prophylactic use of ephedrine and
phenylephrine were both effective in preventing maternal hypotension during cesarean
section under spinal anesthesia, but phenylephrine was superior to ephedrine in treating
hypotension which was evidenced by higher umbilical cord arterial and venous pH
values.
Adigun, Amanor-Boadu, and Soyannwo (2010) conducted a randomized, doubleblind, controlled study of 62 parturients that compared intravenous ephedrine against
phenylephrine for the maintenance of arterial blood pressure during elective caesarean
section under spinal anaesthesia. The parturients included were those that were classified
as American Society of Anesthesiologists’ (ASA) class 1 or 2 at term with singleton
pregnancy who consented to a subarachnoid spinal block. The patients were injected
with 2.5 milliliters of 0.5% hyperbaric Bupivicaine at L3-L4 levels after being preloaded
with 10 milliliters per kilogram of crystalloid fluids (Adigun et al., 2010). Phenylephrine
100 micrograms or Ephedrine 5 milligrams was given for the maintenance of arterial
blood pressure. The group determined that both vasopressors efficiently restored both the
systolic and the diastolic blood pressures and the mean Apgar scores were similar for the
two groups. Neither the phenylephrine group nor the ephedrine group had Apgar scores
below the value of 8 (Adigun et al., 2010). They concluded that phenylephrine was safe
and can be used as effectively as ephedrine.
A randomized, double-blind study was performed by Prakash, Pramanik,
Chellani, Salhan, and Gogia (2010) on parturients comparing the effects of bolus
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administration of ephedrine and phenylephrine during spinal anesthesia for caesarean
delivery. In the study the group administered phenylephrine 100 micrograms or
ephedrine 6 milligrams whenever the systolic blood pressure dropped less than 80% of
the patient’s baseline blood pressure during the spinal block. The group determined that
changes in systolic were comparable in the two groups after the administration of the two
vasopressors and there were essentially no differences in the incidence of nausea,
bradycardia, and vomiting. However, the group determined venous and umbilical artery
pH blood values were significantly higher in the phenylephrine group as compared to the
ephedrine group. Also, the umbilical artery base excess was significantly less in the
ephedrine group than in the phenylephrine group (Prakash et al., 2010). Apgar scores at
1, 5, and 10 minutes were measured as well as neurobehavioral scores at 2-4 hours, 24
hours, and 48 hours and were determined to be similar in the two vasopressor groups.
Simin, Zahra, Pouya, and Reza (2012) conducted a prospective, double-blind, and
case-controlled study on 60 parturients. They studied the efficacy of ephedrine and
phenylephrine in treatment of hypotension secondary to spinal anesthesia for cesarean
section and the effects the two vasopressors had on the neonate. The group randomly
assigned the 60 parturients into an ephedrine group, which received boluses of 5
milligrams, and a phenylephrine group, which received boluses of 100 micrograms, for
treatment of hypotension after a subarachnoid spinal block during cesarean section. They
studied changes in maternal heart rate, maternal blood pressure, and the incidence of
nausea and vomiting. Additionally the group measured neonatal umbilical arterial blood
gas values and Apgar scores at 1 minute and 5 minutes. The group determined that both
vasopressors were efficient at managing hypotension in parturients undergoing cesarean
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section with comparable results. Also there were no differences in Apgar scores at 1
minute and 5 minutes after administration of either vasopressor. There were only
minimal differences in the umbilical artery pH and base excess values and there were not
any incidents of true acidosis, pH less than 7.20, in any of the neonates. Thus, the group
concluded that both phenylephrine and ephedrine were both equally efficient at treating
hypotension secondary to subarachnoid block during cesarean section and neither
vasopressor presented a risk for adverse effects on neonates.
Cooper et al. (2002) performed a randomized, double- blind study on 147
parturients to determine whether ephedrine, phenylephrine, or a combination of the two
was the most efficient at treating hypotension secondary to spinal block and whether or
not the two vasopressors caused adverse effects to the neonate. The group randomly
divided the patient groups into three different groups: a phenylephrine group which
received 100 micrograms/milliliter, an ephedrine group which received 3
milligrams/milliliter, and a combination group that received 50 micrograms/milliliter of
phenylephrine and 1.5 milligrams/milliliter. These groups were selected by envelope to
one of the three vasopressor solutions to maintain maternal systolic pressure during spinal
anesthesia. The group determined that fetal acidosis was found to be more frequent in the
ephedrine group (10 of 48) and less frequent in the phenylephrine group (1 of 48) and
combination group (1 of 47). The group also determined that there is no significance
difference among the different vasopressor categories in regards to the measurement of
Apgar scores. All vasopressor groups had Apgar scores above 8 and are thus deemed
insignificant. The group concluded that administering phenylephrine alone by infusion
during spinal anesthesia for cesarean section was associated with a lower incidence of
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maternal nausea and vomiting and fetal acidosis than giving ephedrine alone (Cooper et
al., 2002). Furthermore, the group determined that it was not advantageous to combine
phenylephrine and ephedrine because it increased nausea and vomiting as compared to
phenylephrine alone. It also did not improve fetal blood gas values additionally than from
administering just phenylephrine.
A systematic literature search was conducted by Veeser et al. (2012) on
comparing the administration of phenylephrine and ephedrine to hypotensive parturients
after undergoing spinal anesthesia for cesarean section. The outcomes they measured
were the maternal and neonatal effects of the two vasopressors. The authors study
criteria was fulfilled by 20 trials, which included 1,069 patients. The neonatal outcomes
measured were umbilical-artery pH, base excess, and Apgar scores. The investigators
determined the relative ratio, or RR, of fetal acidosis was 5.29 (95%CI 1.62-17.25) for
ephedrine compared with phenylephrine, which was statistically significant data (P =
0.006) (Veeser et al., 2012). Veeser et al. (2012) also determined that the data
accumulated on base excess was significantly lower in the ephedrine group. The
weighted mean difference was -1.17 with a 95% confidence interval of -2.01 and P value
of 0.006. The number of neonates with Apgar values less than 7 were measured in 11
trials at 1 and 5 minutes after delivery. The only significant score present was a single
Apgar value below 7 at 5 minutes in one study. All other Apgar data when comparing
phenylephrine to ephedrine was statistically insignificant. The investigators concluded
that ephedrine use was associated with an increased risk of true fetal acidosis when
compared with phenylephrine. Additionally, ephedrine use also increased the risk for a
lower base excess value. The study yielded that the Apgar values did not significantly
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differ between the two vasopressors (Veeser et al., 2012). The results of this study are
clinically significant for my capstone project.
Loughrey et al. (2005) conducted a randomized control trial of 43 ASA I and II
non-laboring women undergoing a planned, elective cesarean delivery. The investigators
randomized the 43 parturients into 2 groups. The ephedrine only group received a bolus
of ephedrine 10 milligrams intravenously. The ephedrine and phenylephrine combine
group received a bolus of phenylephrine 40 micrograms and ephedrine 10 milligrams
simultaneously with spinal anesthesia (Loughrey et al., 2005). The group defined
hypotension for this study to be a decrease of 20% or greater from the baseline systolic
value or any value less than 100 mmHg. Loughrey et al. would give rescue boluses
comprised of phenylephrine 20 micrograms and ephedrine 5 milligrams. The results
from the study yielded that the mean umbilical artery pH being 7.246 +/- 0.081 for the
ephedrine only group and 7.244 +/- 0.106 for the combined ephedrine and phenylephrine
group. Apgar scores measured for the two groups were also similar and neither group
had one that measured less than 7 (Loughrey et al., 2005). This study determines that
there was no significant difference between the groups and that a combination of
ephedrine with phenylephrine is not superior to ephedrine alone.
Doctor of Nursing Practice Essentials
DNP Essential I is the scientific underpinning for practice (Chism, 2013). This
DNP essential allows the researcher to employ science-based theories and concepts to
describe strategies used to improve healthcare delivery, to determine the importance and
nature of health and healthcare delivery phenomena, and to evaluate outcomes. The
theory I plan to integrate into this capstone project is a middle-range theory. Middle-
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range theory is a less abstract, has fewer propositions and concepts than grand theory, and
is narrower in scope (Butts & Rich, 2011). The type of theory I plan to integrate into the
capstone project is the prescriptive theory or practice theory. This model falls within
Ernestine Wiedenbach’s model of nursing theory, The Helping Art of Clinical Nursing.
The prescriptive theory is fundamentally based on three main factors: the central purpose
which the clinical nurse recognizes as crucial to the particular discipline, the realities in
the immediate situation that influence the central purpose, and the prescription for the
fulfillment of the central purpose. According to Butts and Rich (2011), prescriptive
theory is an empirical, experimental theory for practice based on the effects of processes
and actions on people and situations. The use of this theory will help to discover whether
phenylephrine or ephedrine is safer to administer in obstetric anesthesia.
DNP Essential II is the organizational and systems leadership for quality
improvement and systems thinking (Chism, 2013). This DNP essential employs
scientific findings in nursing to evaluate and develop care delivery methods that meet the
current and future needs of patient populations. This capstone is designed to evaluate
research conducted comparing the administration of phenylephrine and ephedrine to
hypotensive parturients undergoing spinal anesthesia for cesarean section. The method
that will determine the difference between these two vasopressors is by measuring the
neonates Apgar scores at 1 and 5 minutes and also by measuring fetal cord blood pH
measurements. Both vasopressors appropriately treat hypotension in the parturient but
current research is controversial on which one is safer for the neonate. This capstone
intends to yield a clear answer on which is more beneficial for the neonate and a clinical
practice change will be implemented to improve patient safety.
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DNP Essential III is the clinical scholarship and analytical methods for evidencebased practice (Chism, 2013). This DNP essential prepares the nurse researcher to
critically and analytically evaluate existing literature and other evidence to determine the
best evidence for practice. This essential also aids in evaluating outcomes in practice
within populations in various fields. Additionally this essential helps the nurse researcher
develop practice guidelines that are based on relevant, best-practice findings. This
capstone will systematically review research conducted by other researchers and will
gather their results into a systematic review of the literature. The results will then be
synthesized into a white paper proposal for the treatment of spinal induced hypotension
during cesarean section.
DNP Essential IV is the information systems and technology and patient care
technology for the improvement and transformation of health care. This DNP essential is
paramount for the researcher in becoming proficient at the skills necessary to evaluate
data extraction from practice information databases and systems. This essential also aids
the researcher to monitor and evaluate outcomes of care improvement by evaluating,
designing, and using programs related to information technologies. Electronic databases
will be utilized for this capstone project to conduct my review of literature and to find
relevant neonatal outcomes after cesarean delivery to supplement my research findings.
Information technologies will also be employed to help synthesize the data into a metaanalysis extracted from research studies.
DNP Essential V is healthcare policy for advocacy in healthcare (Chism, 2013).
This essential is vital for the nurse researcher because it prepares them to provide
leadership in the implementation and development of healthcare policy at the institutional
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and local levels of healthcare, as well as the state and federal levels. After the results of
the capstone have been gleaned, a white paper proposal will be prepared to advocate for
policy change at local clinical arenas in regards to obstetric anesthesia. This will improve
the quality of care and hopefully improve neonatal outcomes after cesarean section by
treating parturient hypotension with the safest vasopressor.
DNP Essential VI is interprofessional collaboration for improving patient and
population health outcomes (Chism, 2013). This essential is critical because the DNP
prepared nurse must participate in effective collaboration and communication throughout
the development of practice guidelines, practice models, health policy, peer review, and
standards of care. The DNP prepared nurse must also examine complex organizational or
practice issues through leadership of interprofessional teams. Interprofessional
collaboration is essential for the implementation of the practice change to be effective
and to improve neonatal outcomes. Additionally, communication with all anesthesia
providers and department supervisors about the new white paper proposal is imperative
for the latest evidenced based practice to be successfully implemented.
DNP Essential VII is clinical prevention and population health for improving the
nation’s health. According to Allan et al., clinical prevention is defined as reducing risk,
illness prevention, and health promotion for families and individuals (Allan, et al., 2004).
This essential prepares DNP level nurses to analyze biostatistical, environmental,
epidemiological, and occupational data in the development, evaluation, and
implementation of population health and clinical prevention (Chism, 2013). The
administration of ephedrine as a first line vasopressor for the prevention of hypotension
in the parturient following spinal anesthesia for cesarean delivery can potentially lead to
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decreased Apgar scores and fetal acidosis in the neonate. Fetal acidosis in the neonate
can lead to detrimental health complications like hypoxia, which can then potentially lead
to cardiovascular collapse and mortality in the neonate. By implementing the latest
evidenced based practice based on the results of this capstone, neonatal complications
can be avoided by administering phenylephrine as a first line vasopressor.
DNP Essential VIII is advanced nursing practice (Chism, 2013). This essential is
vital and prepares the DNP nurse to systematically assess health and illness parameters
while incorporating culturally sensitive and diverse approaches. By utilizing this DNP
Essential, the DNP prepared nurse will also evaluate and implement therapeutic
interventions based on nursing and other sciences. Additionally, the DNP nurse will be
able to utilize advanced critical thinking skills and deliver and evaluate evidence based
care to improve patient outcomes. The utilization of this DNP essential will lead the
anesthesia provider to utilize the latest evidence based practice provided by this capstone
and provide the most optimal care to the parturient during cesarean delivery.

28
White Paper Change Proposal
The most commonly performed major surgical procedure in the United States
today is cesarean delivery, accounting for more than 1 million procedures each year and
approximately 30% of all births. The most commonly preferred method of anesthesia for
elective cesarean section is with a spinal anesthetic. Spinal anesthesia delivers a fast onset
of dense neuroblockade that is normally more profound than that which is provided by
the epidural technique. When spinal anesthesia is used as the anesthetic method for
cesarean delivery, it causes maternal hypotension at a rate of 80%. Hypotension is the
medical definition for low blood pressure. Blood Pressure is the measure of the pressure
in the arteries that is created by the contraction of the heart. Hypotension, if sustained
and severe, can lead to fetal hypoxia, neonatal depression or injury, and decreased
uteroplacental perfusion. Although patients undergoing a spinal anesthetic are usually
preloaded with intravenous fluids, a vasopressor is often required to treat hypotension
after the spinal anesthetic takes effect.
Historically, the vasopressor of choice to treat hypotension for obstetric
anesthesia has been ephedrine. This assumption was based on observations researchers
had when administering ephedrine to sheep. In the study, ephedrine showed it maintained
and preserved uteroplacental blood flow better than other vasopressors. It also was the
most effective in increasing arterial pressure than other vasopressors. This effect is
rationalized by the β-effect, which causes an increase in arterial blood pressure by
increasing cardiac output rather than simply vasoconstriction. Phenylephrine, a pure α
agonist, on the other hand had fell into disfavor as a vasopressor in obstetric anesthesia
because of the decreased uteroplacental blood flow seen in the same sheep study. A

29
systematic review of the literature was performed and the results of randomized control
trials and other studies were analyzed that measured neonatal outcomes following the
administration of ephedrine and phenylephrine to the hypotensive parturient.
The purpose of this project was to determine whether ephedrine or phenylephrine
is safer for the neonate when administered to a hypotensive parturient during elective
cesarean section. The desired outcome was to improve patient safety by developing a
practice change policy based upon the findings of the systematic review of the literature.
The outcomes that were measured for this study to determine this was Apgar scores
recorded at 1 and 5 minutes and umbilical artery pH. These are standard assessments that
are performed following the removal of the neonate during cesarean section that
determine the current health status of the neonate.
One of the major findings of this systematic review of the literature was that there
was no significant difference in Apgar scores when comparing the administration of
ephedrine and phenylephrine. There were eight studies reviewed in this capstone project
that measured Apgar scores comparing ephedrine versus phenylephrine, and seven of
them determined that there was no significant difference. The value that was deemed
significant in these studies was an Apgar value below seven. In one study, the
administration of ephedrine to the parturient during cesarean delivery caused lower
Apgar scores at 1 minute, but when the measurement was repeated at five minutes it was
above seven and considered normal. The 5-minute score has commonly been regarded as
the best predictor of the neonate’s survival in clinical practice.
The second neonatal outcome that was reviewed in this systematic review was the
measurement of umbilical pH values. The results of the review yielded some significant
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and interesting results. There were eight studies in this capstone project that measured
neonatal umbilical pH values. After reviewing these studies, five confirmed that
ephedrine causes lower umbilical pH values in the neonate when given to the parturient
during cesarean delivery. The other three studies deemed the results to be similar or
insignificant in their findings. Small changes in pH can significantly affect the function of
various organ systems in the neonate including the cardiovascular system and the central
nervous system.
Based on the information discovered by this capstone project, phenylephrine is
just as safe for neonates as ephedrine and is safer in regards to neonatal umbilical pH
values. This capstone recommends the use of phenylephrine over ephedrine as a first line
vasopressor to treat maternal hypotension during cesarean delivery secondary to spinal
anesthesia. It is also recommended that the proposed changes made with the white paper
proposal be tested for accuracy to determine if the results of the studies are significant
enough to warrant a wholesale clinical practice change.
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CHAPTER IV
SUMMARY
The purpose of this project was to determine whether ephedrine or phenylephrine
was safer for the neonate when administered to a hypotensive parturient during elective
cesarean section. The outcomes that were measured for this study to determine this was
Apgar scores recorded at 1 and 5 minutes and umbilical artery pH. These are standard
assessments that are performed following the removal of the neonate during cesarean
section that determine the current health status of the neonate. A systematic review of the
literature was performed and the results of randomized control trials and other studies
were analyzed that measured neonatal outcomes following the administration of
ephedrine and phenylephrine to the hypotensive parturient.
Summary of Findings
One of the major findings of this systematic review of the literature was that there
was no significant difference in Apgar scores when comparing the administration of
ephedrine and phenylephrine. There were eight studies reviewed in this capstone project
that measured Apgar scores comparing ephedrine versus phenylephrine, and seven of
them determined that there was no significant difference. The value that was deemed
significant in these studies was an Apgar value below 7. In one study, the administration
of ephedrine to the parturient during cesarean delivery caused lower Apgar scores at 1
minute, but when the measurement was repeated at 5 minutes it was above 7 and
considered normal. The 5-minute score has commonly been regarded as the best
predictor of the neonate’s survival in clinical practice (Casey et al., 2001).
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The second neonatal outcome that was reviewed in this systematic review was the
measurement of umbilical pH values. The results of the review yielded some significant
and interesting results. There were eight studies in this capstone project that measure
neonatal umbilical pH values. After reviewing these studies, five confirmed that
ephedrine causes lower umbilical pH values in the neonate when given to the parturient
during cesarean delivery. The other three studies deemed the results to be similar or
insignificant in their findings. This is significant because the majority of the studies
determined that there is a correlation between the administration of ephedrine to
parturients and lower umbilical pH measurements in neonates. Historically, the
vasopressor of choice to treat hypotension for obstetric anesthesia has been ephedrine.
However, this capstone has shown that phenylephrine is just as effective as ephedrine and
has shown to possibly be a safer alternative for the neonate based on the reviewed
measurements of neonatal umbilical pH values.
Recommendations
The review of literature showed that there was little to no significant difference
when comparing ephedrine and phenylephrine and the measurement of neonatal Apgar
scores. However, the literature review did yield interesting results and the majority
determined that ephedrine did cause a lower pH when compared with phenylephrine.
This is a significant correlation and one that needs to be studied further for greater
accuracy. This capstone project proposes that changes made with the white paper
proposal be tested for accuracy to determine if the results of the studies are significant
enough to warrant a wholesale clinical practice change.
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Conclusion
The goal of this capstone was to determine whether it is safer for the neonate to
administer ephedrine or phenylephrine to the hypotensive parturient during cesarean
delivery. The desired outcome was to improve patient safety by developing a practice
change policy based upon the findings of the systematic review of the literature. The
findings of this capstone project may not have proven one vasopressor to be without
question safer for neonates than the other. However, this project did provide a correlation
between decreased umbilical pH values and the administration of ephedrine to
hypotensive parturients following the administration of spinal anesthesia for cesarean
delivery. It is my belief that this capstone project will be beneficial in providing local
clinical sites with current evidence-based practice on the administration of ephedrine and
phenylephrine to hypotensive parturients and the neonatal outcomes that each
vasopressor causes.

34
REFERENCES
Adigun, T., Amanor-Boadu, S., & Soyannwo, O. (2010, March). Comparison of
intravenous ephedrine with phenyephrine for the maintenance of arterial
blood pressure during elective caesarean section under spinal anaesthesia.
African Journal of Medicine and Medical Sciences, 39(1), 13-20.
Allen, T. K., Muir, H. A., George, R. B., & Habib, A. S. (2009). A survey of the
management of spinal-induced hypotension for scheduled cesarean delivery.
International Journal of Obstetric Anesthesia, (18), 356-361.
Barash, P. G., Cullen, B. F., Stoelting, R. K., Cahalan, M. K., Stock, M. C., & Ortega, R.
(2013). Clinical Anesthesia (7th ed.). Philadelphia, PA: Lippincott Williams &
Wilkins.
Burns, S. M., Cowan, C. M., & Wilkes, R. G. (2001, August). Prevention and
management of hypotension during spinal anaesthesia for elective caesarean
section: a survey of practice. Anaesthesia, 56(8), 777-798.
Butterworth, J. F., Mackey, D. C., & Wasnick, J. D. (2013). Morgan & Mikhail's Clinical
Anesthesiology. New York: McGraw-Hill Companies, Inc.
Butts, J. B., & Rich, K. L. (2011). Philosophies and Theories for Advanced Nursing
Practice. Sudbury, MA: Jones & Bartlett Learning.
Casey, M. B., McIntire, D. D., & Leveno, K. J. (2001, February 15). The Continuing
Value of the Apgar Score for the Assessment of Newborn Infants. The New
England Journal of Medicine, (344), 467-471.

35
Chestnut, D. H., Wong, C. A., Tsen, L. C., Ngan Kee, W. D., Beilin, Y., & Mhyre, J. M.
(2014). Chestnut's Obstetric Anesthesia Principles and Practice. Philadelphia,
PA: Elsevier Saunders.
Chism, L. A. (2013). The Doctor of Nursing Practice. Burlington, MA: Jones & Bartlett
Learning.
Cooper, D. W., Carpenter, M., Mowbray, P., Desira, W. R., Ryall, D. M., & Kokri, M. S.
(2002). Fetal and Maternal Effects of Phenylephrine and Ephedrine during
Spinal Anesthesia for Cesarean Delivery. Anesthesiology, 97(6), 1582-90.
Habib, A. S. (2012, February ). A Review of the Impact of Phenylephrine
Administration on Maternal Hemodynamics and Maternal and Neonatal
Outcomes in Women Undergoing Cesarean Delivery Under Spinal Anesthesia.
Anesthesia & Analgesia, 114(2), 377-390.
Harrop-Griffiths, W. (2002). Ephedrine is the vasopressor of choice for obstetric
regional anaesthesia. International Journal of Obstetric Anaesthesia, (11),
275-281.
Lee, A., Ngan Kee, W. D., & Gin, T. (2002). A Quantitative, Systematic Review of
Randomized Controlled Trials of Ephedrine Versus Phenylephrine for the
Management of Hypotension During Spinal Anesthesia for Cesarean Delivery
. Anesthesia & Analgesia, 94(4), 920-926.
Lin, F.Q., Qui, M.T., Ding, X.X., Fu, S.K., & Li, Q. (2012). Ephedrine Versus
Phenylephrine for the Management of Hypotension During Spinal Anesthesia
for Cesarean Section: An Updated Meta-Analysis. CNS Neuroscience &
Therapeutics, 18(7), 591-597.

36
Loughrey, J., Yao, N., Datta, S., Segal, S., Pian-Smith, M., & Tsen, L. (2005).
Hemodynamic effects of spinal anesthesia and simultaneous intravenous
bolus of combined phenylephrine and ephedrine versus ephedrine for
cesarean delivery. International Journal of Obstetric Anesthesia, (14), 43-47.
Macarthur, A., & Riley, E. T. (2007). Obstetric Anesthesia Controversies: Vasopressor
Choice for Postspinal Hypotension During Cesarean Delivery. International
Anesthesiology Clinics, (1), 115-32.
Magalhaes, E., Goveia, C. S., de Araujo Ladeira, L. C., Nascimento, B. G., & Cavalcante
Kluthcouski, S. M. (2009). Ephedrine versus phenylephrine: prevention of
hypotension during spinal block for cesarean section and effects on the fetus.
Revista Brasieira de Anestesiologia, 59(1), 11-20.
Nagelhout, J. J., & Plaus, K. L. (2014). Nurse Anesthesia (5th ed.). St. Louis, MO:
Elsevier Saunders.
Omo-Aghoja, L. (2014). Maternal and Fetal Acid-Base Chemistry: A Major
Determinant of Perinatal Outcome. Annals of Medical and Health Sciences
Research, 4(1), 8-17.
Prakash, S., Pramanik, V., Chellani, H., Salhan, S., & Gogia, A. (2010). Maternal and
neonatal effects of bolus administration of ephedrine and phenylephrine
during spinal anaesthesia for caesarean delivery: a randomised study.
International Journal of Obstetric Anesthesia, (19), 24-30.
Simin, A., Zahra, F., Pouya, H. M., & Reza, T. (2012). Comparison the effect of
ephedrine and phenylephrine in treatment of hypotension after spinal

37
anesthesia during cesarean section. Open Journal of Obstetrics and
Gynecology, (2), 192-196.
Veeser, M., Hofmann, T., Roth, R., Klohr, S., Rossaint, R., & Heesen, M. (2012).
Vasopressors for the management of hypotension after spinal anesthesia for
elective cesarean section. Systematic review and cumulative meta-analysis.
Acta Anaesthesiologica Scandinavica, (56), 810-816.

